¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Chronic viral hepatitis B without delta- agent"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • neonatal hepatitis
    ½Å»ý¾Æ°£¿°(~ÊÜæú).
  • non-A, non-B, hepatitis=NANBH
    ºñAºñB °£¿°
  • non-A, non-B, non-C hepatitis
    ºñA ºñB ºñC °£¿°
  • post transfusion hepatitis
    ¼öÇ÷Èİ£¿°.
  • posttransfusion hepatitis
    ¼öÇ÷Èİ£¿°.
  • serum hepatitis
    Ç÷û°£¿°
  • serum hepatitis
    Ç÷û°£¿°(¡­ÊÜæú).
  • serum hepatitis
    Ç÷û¸Å°³°£¿°
  • serum hepatitis
    Ç÷û°£¿°(¡­ÊÜæú)
  • subclinical hepatitis B
    ¹«Áõ»ó(ÙíñøßÒ) B Çü°£¿°
  • suppurative hepatitis
    È­³ó¼º °£¿°(¡­ÊÜæú).
  • suppurative hepatitis
    È­³ó¼º °£¿°(¡­ÊÜæú)
  • toxic hepatitis
    µ¶¼º°£¿°(Ô¸àõÊÜæú)
  • toxipathic hepatitis
    µ¶¹°¼º °£¿°(Ô¸ÚªàõÊÜæú).
  • transfusion hepatitis
    ¼öÇ÷°£¿°(¡­ÊÜæú).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 12
CWPEA Childbirth Without Pain Education Association
CWW clinic without walls
GPWW group practice without wall
LWBS leaving [hospital] without being seen
MSF macrophage slowing factor; macrophage spreading factor; Medicins sans Frontieres [Doctors without Bo...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 12
AAV Adeno-associated viral
VCA Anti-viral capsid antigen
BVD Bovine Viral Diarrhea
BVDV Bovine Viral Diarrhea Virus
BVD-MD Bovine viral diarrhea-mucosal disease
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • chronic lupus erythematosus
    ¸¸¼º È«¹Ý¼º ·çǪ½º
  • chronic lymphocytosis
    ¸¸¼º ¸²ÇÁ±¸ Áõ°¡Áõ
  • chronic marginal gingivitis
    ¸¸¼º º¯¿¬ Ä¡Àº¿°, ¸¸¼º º¯¿¬¼º Ä¡Àº¿°
  • chronic meningoencephalitis
    ¸¸¼º ¼ö¸· ³ú¿°
  • chronic motor or vocal tic disorder
    ¸¸¼º ¿îµ¿¼º ȤÀº À½¼ºÆ½ Àå¾Ö
  • chronic mucocutaneous candidiasis
    ¸¸¼º Á¡¸· ÇǺΠĵµð´ÙÁõ, ¸¸¼º Á¡¸· Ç¥ÇǼº ĵµð´ÙÁõ, ¸¸¼º Á¡¾× Á¡¸· Ä­µð´ÙÁõ
    1. Ä­µð´Ù¿¡ ÀÇÇØ »ý±â´Â Ç¥À缺 Áø±ÕÁõÀ¸·Î ÇǺΠ¶Ç´Â Á¡¸·À» ħÅõÇÏ´Â °ÍÀ» ¸»ÇÑ´Ù. ¼¼Æ÷¼º ¸é¿ªºÎÀüÀ» ¹è°æÀ¸·Î À¯¼Ò¾Æ±â¿¡ ¹ß»ýÇÏ´Â ÇǺÎÁ¡¸· ö °áÇ̼º ºóÇ÷, ºñŸ¹Î A °áÇÌÁõ ÇÕº´ÀÌ º¸À̰í À¯Àü Çü½Ä µî¿¡ µû¶ó ¸î °¡Áö·Î ºÐ·ùµÇ°í ÀÖ´Ù. 2. ´Ù¾çÇÑ ÇüÅÂÀÇ ³»ÀçµÈ ¸é¿ª ÀÌ»óÀ» °¡Áø ȯÀÚ´Â ¶§¶§·Î ÇǺÎ, ¼ÕÅé, ±×¸®°í ±¸°­ Á¡¸·¿¡ ±¤¹üÀ§ÇÑ Äµµð´ÙÀÇ ±ºÁýÀ» º¸¿©ÁØ´Ù. ±×¸®°í ÃþÀ» ÀÌ·é µÎ²¨¿î À§¸·ÀÌ Çü¼ºµÈ´Ù.
  • chronic muscle tension
    ¸¸¼º ±ÙÀ° ±äÀå
  • chronic myelitis
    ¸¸¼º ô¼ö¿°
  • chronic myelogenous leukemia
    ¸¸¼º °ñ¼ö¼º ¹éÇ÷º´
    ¸¸¼º °ñ¼ö¼º ¹éÇ÷º´Àº Àå³âÃþ¿¡ ÁÖ·Î ¹ß»ýÇÏ¸ç ¹éÇ÷º´ÀÇ ´ëºÎºÐÀ» Â÷ÁöÇÑ´Ù. ¸¸¼º °ñ¼ö¼º ¹éÇ÷º´Àº Á¶Ç÷¸ð¼¼Æ÷ ¼öÁØÀÇ ¾Ï¼º Áõ½ÄÀ¸·Î Áø¼º ÀûÇ÷±¸ Áõ°¡Áõ, Ç÷¼ÒÆÇ Áõ°¡Áõ ¹× °ñ¼ö ¼¶À¯È­Áõ°ú ÇÔ²² °ñ¼ö Áõ½Ä¼º ÁúȯÀ¸·Î ºÐ·ùµÈ´Ù. ¿°»öü 9¹ø°ú 22¹øÀÇ »óÈ£ ÀüÀ§·Î ÀÎÇÑ Çʶóµ¨ÇÇ¾Æ ¿°»öü¿Í ±× »ê¹°ÀÎ bcr-ablÀÌ 95% À̻󿡼­ ¾ç¼ºÀ¸·Î ÀÌ ÁúȯÀÇ º´Àΰú °ü°è°¡ ÀÖ´Â °ÍÀ¸·Î ÀÌÇØµÇ°í ÀÖ´Ù. ÁÖ Áõ»óÀº ºñÀå ºñ´ë·Î ÀÎÇÑ º¹ºÎ ÆØ¸¸ÀÌ Æ¯Â¡ÀûÀÌ¸ç ±×¿Ü °ú´ë»çÁõ µî ÀϹÝÀûÀÎ ¹éÇ÷º´ÀÇ Áõ»óÀÌ ÀÖ´Ù. Áø´ÜÀº Ç÷¾× ¼Ò°ß°ú °ñ¼ö ¼Ò°ß ±×¸®°í ¿°»öü ¹× ºÐÀÚ»ý¹°ÇÐ °Ë»ç¿¡ ÀÇÇÑ bcr-abl ÀÇ Áõ¸í¿¡ ÀÇÇÑ´Ù. ÀÌ ÁúȯÀÇ °æ°ú´Â ¾à 3³âÀÇ ¸¸¼º±â¸¦ Áö³ª°í Àüȯ±â¸¦ °Åó ±Þ¼º ¹éÇ÷º´À¸·Î ÀüȯµÇ¸ç À̶§´Â ÇöÀç ¾Ë·ÁÁø ¾î¶°ÇÑ Ä¡·á ¹æ¹ý¿¡µµ Àß ¹ÝÀÀÇÏÁö ¾Ê´Â´Ù. Ä¡·á´Â °ú°Å¿¡´Â busulfan À̶ó´Â Ç×¾ÏÁ¦°¡, ±Ù·¡¿¡´Â hydrea°¡ ÁÖ·Î »ç¿ëµÇ°í ÀÖÀ¸³ª À̵éÀº ±Þ¼º ¹éÇ÷º´À¸·ÎÀÇ ÀüȯÀ» ¸·Áö ¸øÇÏ¸ç ¹éÇ÷±¸ÀÇ Á¶Àý¿¡¸¸ µµ¿òÀÌ µÉ »Ó Çʶóµ¨ÇÇ¾Æ ¿°»öü°¡ ÀÖ´Â ¾Ï¼¼Æ÷¸¦ Á¦°ÅÇÏÁö´Â ¸øÇÑ´Ù. ±Ù·¡¿¡´Â homoharringtonine µîÀÇ ¾àÁ¦°¡ ¿¬±¸µÇ°í ÀÖ´Ù. 1990³â´ë ¿¡ µîÀåÇÑ ¾ËÆÄÀÎÅÍÆä·Ð ¿ä¹ýÀº ¾à 80%¿¡¼­ Ç÷¾× ¼Ò°ßÀÌ Á¤»óÈ­µÇ°í 20-30%¿¡¼­ Çʶóµ¨ÇÇ¾Æ ¿°»öü°¡ ¼Ò½ÇµÇ´Â µî ¿ì¼öÇÑ ¼ºÀûÀ» º¸À̰í ÀÖÀ¸³ª ±Þ¼º ¹éÇ÷º´À¸·ÎÀÇ ÀüȯÀ» ¸·Áö´Â ¸øÇÏ¸ç ¸¸¼º±â¸¦ ¾à 5³â Á¤µµ·Î ¿¬Àå½ÃŲ´Ù. ¸¸¼º °ñ¼ö¼º ¹éÇ÷º´À» ¿ÏÄ¡½Ãų ¼ö ÀÖ´Â À¯ÀÏÇÑ Ä¡·á ¹æ¹ýÀº µ¿Á¾ °ñ¼ö À̽ÄÀ¸·Î 55¼¼±îÁö ½ÃÇàÀÌ µÈ´Ù. °ñ¼ö ÀÌ½Ä ÈÄ Àå±â ¹«º´ »ýÁ¸À²Àº ¾à 60-70%ÀÌ¸ç Æ¯È÷ Áø´ÜµÈ ÈÄ 1³â À̳»¿¡ ½ÃÇàÇÏ´Â °ÍÀÌ ±Ç°íµÈ´Ù.
  • chronic myelomonocytic leukemia
    ¸¸¼º °ñ¼ö¼º ´Ü±¸ ¹éÇ÷º´
  • chronic myocarditis
    ¸¸¼º ½É±Ù¿°
  • chronic nociceptive input
    ¸¸¼º Ä§ÇØ¼ö¿ë¼º ÀÔ·Â, ¸¸¼º À¯Çؼö¿ë¼º ÀÔ·Â
  • chronic nonspecific dermatitis
    ¸¸¼º ºñƯÀ̼º ÇǺο°
  • chronic organic brain syndrome
    ¸¸¼º ±âÁú¼º ³ú ÁõÈıº
  • chronic osteomyelitis
    ¸¸¼º °ñ¼ö¿°
    ¾àÇÑ Àڱؿ¡ ÀÇÇØ »ý±â¸ç ÁÖº¯¿¡ °ñ Çü¼ºÀ» µ¿¹ÝÇÑ °ñ¸·ÀÇ ±¹¼ÒÀû Áõ»óÀÌ´Ù. °ÅÀÇ ÀþÀº »ç¶÷¿¡¼­ ¹ß»ýÇϸç, È£¹ßºÎ´Â °æ°ñÀÇ Àü¸é°ú ÇϾÇÀÌ´Ù. Ä¡Åë°ú »óÇϾÇÀÇ ÅëÁõÀÌ ³ªÅ¸³­´Ù. ¶§·Î »óÃþÀÇ ¿¬Á¶Á÷ÀÇ °¨¿°À̳ª ºÀ¿ÍÁ÷¿°ÀÇ °á°ú·Î »ý±ä´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
genes, viral The hereditary material of viruses, consisting in all DNA and some RNA viruses of a single molecule of nucleic acid, and in some RNA viruses of several separate pieces of RNA.
(12 Dec 1998)
genome, viral The complete gene complement contained in a DNA or RNA molecule in a virus.
(12 Dec 1998)
viral Pertaining to, caused by or of the nature of virus.
(18 Nov 1997)
viral alkaline nuclease <enzyme> Has both exo and endonuclease activity
Registry number: EC 3.1.-
Synonym: hsv type 1 alkaline nuclease, herpes simplex virus type I alkaline nuclease, alkaline nuclease, herpes simplex virus
(26 Jun 1999)
viral antigen Those antigens specified by the viral genome (often coat proteins) that can be detected by a specific immunological response. Often of diagnostic importance.
(18 Nov 1997)
viral core proteins Proteins found mainly in icosahedral DNA and RNA viruses. They consist of proteins directly associated with the nucleic acid inside the nucleocapsid.
(12 Dec 1998)
viral cystitis Bladder inflammation due to a viral infection.
(05 Mar 2000)
viral dysentery Profuse watery diarrhoea due to, or thought to be due to, infection by a virus.
(05 Mar 2000)
viral encephalomyelitis An encephalomyelitis due to a neurotropic virus.
(05 Mar 2000)
viral envelope The outer structure that encloses the nucleocapsids of some viruses; may contain host material.
(05 Mar 2000)
viral envelope proteins Layers of protein which surround the capsid in animal viruses with tubular nucleocapsids. The envelope consists of an inner layer of lipids and virus specified proteins also called membrane or matrix proteins. The outer layer consists of one or more types of morphological subunits called peplomers which project from the viral envelope; this layer always consists of glycoproteins.
(12 Dec 1998)
viral fusion proteins Proteins, usually glycoproteins, found in the viral envelopes of a variety of viruses. They promote cell membrane fusion and thereby may function in the uptake of the virus by cells.
(12 Dec 1998)
viral gastroenteritis <pathology> An inflammatory condition of the intestines that results from an infection with a virus. Rotavirus is a common cause. Abdominal pain, diarrhoea, nausea and vomiting are common symptoms.
(27 Sep 1997)
viral haemagglutination The nonimmune agglutination of suspended red blood cells by certain of a wide range of otherwise unrelated viruses, usually by the virion itself but in some instances by products of viral growth, the species of erythrocyte agglutinated differing with the different viruses.
See: haemagglutination inhibition.
(05 Mar 2000)
viral haemorrhagic fever An epidemic viral illness seen in southern Sudan and Zaire, caused by the Ebola virus. The illness is characterised by fever, malaise, muscle aches, respiratory symptoms, diarrhoea, vomiting, epistaxis, haemoptysis, haematemesis, rash, tremors and subconjunctival haemorrhages. Transmitted by close bodily contact with infected individuals (blood, faeces and body fluids). Incubation is-21 days with initial symptoms of fever and headache. There is no specific treatment and death can occur within 10 days.
(27 Sep 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 12
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 12
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 12
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 12
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 12
ÅëÇÕ°Ë»ö ¿Ï·á